case 2: testing for egfr in lung adenocarcinoma
Published 5 years ago • 131 plays • Length 5:00Download video MP4
Download video MP3
Similar videos
-
6:59
case 2: diagnosing pd-l1 and egfr lung adenocarcinoma
-
3:09
case 2: osimertinib in egfr-mutated lung cancer
-
5:13
case 2: frontline therapy in egfr-mutated lung cancer
-
5:34
case 2: pd-l1 and egfr lung adenocarcinoma
-
4:28
mutation testing for advanced lung cancer
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
3:47
case overview: egfr-positive nsclc
-
3:06
exploring estrogen receptor roles and targeted therapy in nsclc
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
5:55
a case of egfr-mutant non–small cell lung cancer
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
2:26
egfr mutations in nsclc
-
4:03
approaching a case of egfr non–small cell lung cancer
-
1:41
egfr mutations in patients with lung cancer
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
1:59
treatment options for egfr-positive lung cancer
-
8:36
case study: mutation-negative patient with lung adenocarcinoma
-
2:19
patient summary: egfr-mutant stage 4 lung adenocarcinoma